AAIC 2025 Abstract
MTBR‐tau243 biomarker specifically identifies mixed 3R/4R tauopathies
Study in peopleBiomarkers
Abstract
Background: Insoluble tau aggregates are a defining neuropathological feature of Alzheimer's disease (AD), and primary tauopathies like corticobasal degeneration (CBD), progressive supranuclear palsy (PSP), Pick’s disease (PiD), and frontotemporal lobar degeneration secondary to MAPT mutations (FTLD‐MAPT).
